Together, findings obtained by us and others establish that SAM68 plays a pivotal in lung cancer pathogenesis, and pursuing the understanding of its molecular regulation should help in guiding the development of novel SAM68-based diagnostic or therapeutic reagents. This evidence concerns the gene KHDRBS1 and lung carcinoma.